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Objectives The aim of the present study was to investigate whether right coronary artery chronic total occlusion (CTO) car-
ries prognostic implications in patients undergoing drug-eluting stent–supported percutaneous coronary interven-
tion (PCI) for unprotected left main disease (ULMD).
Background No data exist on the prognostic implication of CTO in patients undergoing PCI for ULMD.
Methods Prospective registry of consecutive patients undergoing PCI for ULMD. Patients with ST-segment elevation myo-
cardial infarction were excluded. Primary endpoints were 6-month and long-term cardiac mortality.
Results From January 2004 to December 2009, 330 patients underwent PCI for ULMD. Of the 330 patients, 78 (24%)
had CTO of the right coronary artery, 22 (7%) had CTO of the left anterior descending artery, and 16 (5%) had
CTO of the left circumflex artery. Patients with right coronary artery CTO had a higher risk profile compared with
patients without right coronary artery CTO. The 6-month mortality rate was 12.8% in patients with right coronary
artery CTO, and 3.6% in patients without right coronary artery CTO (p  0.002), and the 3-year cardiac survival
rate was 76.4  6.8% and 89.7  2.7% (p  0.003), respectively. By multivariable analysis, the only 2 indepen-
dent predictors of 3-year cardiac mortality were right coronary artery CTO (hazard ratio: 2.15, 95% confidence
interval: 1.02 to 4.50; p  0.043) and EuroSCORE (hazard ratio: 1.03, 95% confidence interval: 1.02 to 1.05;
p  0.001).
Conclusions Right coronary artery CTO occurs frequently and is a significant predictor of mortality in patients with ULMD un-
dergoing PCI. (J Am Coll Cardiol 2011;58:125–30) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.02.050Data from registries and randomized trials show an increas-
ing use of percutaneous coronary intervention (PCI) for
unprotected left main disease (ULMD), and a study com-
paring PCI with coronary surgery, the SYNTAX (SYNergy
between Percutaneous Coronary Intervention with TAXus
and Cardiac Surgery) trial, showed in patients with ULMD
that the 2 revascularization strategies are equivalent in terms
of mortality (1–8). However, the SYNTAX trial has shown
that in the subset of patients with ULMD, a high coronary
anatomy complexity, as defined by a SYNTAX score of
33, is associated with a significant increase in the rate of
major adverse cardiovascular events and death (7,8).
From the Division of Cardiology, Careggi Hospital, Florence, Italy. The authors have
reported that they have no relationships to disclose.Manuscript received November 30, 2010; revised manuscript received February 7,
2011, accepted February 22, 2011.High coronary anatomy complexity may result in an
incomplete revascularization PCI, and a large survey study
in the drug-eluting stent (DES) era showed that incomplete
revascularization associated with coronary chronic total
occlusion (CTO) carries a worse outcome and a higher risk
of death compared with complete revascularization (9).
There are no data on the impact of right coronary artery
CTO on the outcome of patients undergoing DES-
supported PCI for ULMD.
The aim of the present study was to investigate whether
right coronary artery CTO carries prognostic implications
in patients undergoing DES-supported PCI for ULMD.
Methods
All consecutive patients who underwent PCI for ULMD
from January 2004 to December 2009 were enrolled in a
prospective registry. Patients with stable coronary artery
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RCA Occlusion in Left Main PCI July 5, 2011:125–30non–ST-segment elevation myo-
cardial infarction were included
irrespective of the coronary anat-
omy. Patients underwent PCI
instead of coronary surgery either
because of patient preference or
the high risk associated with sur-
gery. High surgical risk was de-
fined as a logistic EuroSCORE
of 6 (10).
The study exclusion criteria
were: 1) acute ST-segment ele-
vation myocardial infarction; and
2) anticipated noncompliance with dual antiplatelet treat-
ment for at least 12 months. Multivessel disease was defined
as stenosis 70% of 1, 2, or 3 major coronary arteries on
visual assessment at baseline angiography in addition to the
left main coronary artery lesion. Disease of the left anterior
descending artery and the circumflex artery included lesions
beyond 10 mm from the ostia. CTO was defined as
complete occlusion (Thrombolysis In Myocardial Infarction
flow grade 0) lasting 3 months. Right coronary artery
CTO included only dominant right coronary arteries. Pa-
tients were treated with the intention to achieve complete
revascularization. Completeness of revascularization was
defined as the successful revascularization of all vessels with
a diameter stenosis 70% and a diameter 2 mm on visual
ssessment achieved either during the index hospitalization
r at any time within 30 days after a first PCI.
PCI was performed using standard techniques. For distal
eft main disease, a single-stent technique was preferred in
atients with a normal or diminutive-appearing side branch,
hereas a double-stent technique was considered in patients
ith disease of both the ostia and proximal segments of the
eft anterior descending artery and circumflex artery.
hichever stenting technique was used, routine final kiss-
ng balloon post-dilation with noncompliant balloons had to
e performed in all cases. Procedural adjunctive antithrom-
otic therapy included unfractionated heparin (an initial
olus of 70 U/kg and additional boluses during the proce-
ure to achieve an activated clotting time of 200 to 250 s),
hereas the use of glycoprotein IIb/IIIa inhibitors was at
iscretion of the operator. Chronic antithrombotic treat-
ent included aspirin (300 mg/day indefinitely) and clopi-
ogrel (75 to 150 mg/day for at least 1 year).
The primary endpoints of the study were 6-month and
ong-term cardiac mortality. All deaths were considered
ardiac related unless an unequivocal noncardiac cause could
e documented. Secondary endpoints were: 1) myocardial
nfarction; and 2) repeat percutaneous or surgical coronary
evascularization. The diagnosis of non–Q-wave myocardial
nfarction was based on an increase in creatine kinase-
yocardial band (CK-MB) isoenzyme or troponin I 3
imes the upper limit of normal or, for patients with elevated
alues on admission, a re-elevation of CK-MB or troponin
Abbreviations
and Acronyms
CK-MB  creatine kinase-
myocardial band
CTO  chronic total
occlusion
DES  drug-eluting stent(s)
PCI  percutaneous
coronary intervention
ULMD  unprotected left
main diseasevalues. Q-wave myocardial infarction was defined as the eevelopment of new Q waves in 2 electrocardiographic
eads in addition to CK-MB or troponin I elevation.
K-MB fraction and troponin I were routinely assessed
2 h after PCI in all patients and at least 3 times every 6 h
n patients with recurrent chest pain. Stroke was defined as
n acute neurological defect lasting longer than 24 h.
All patients were scheduled for clinical follow-up at 1, 6,
nd 12 months and yearly thereafter. All other possible
nformation derived from hospital readmission or by the
eferring physician, relatives, or municipality live registries
ere entered into the prospective database. The treatment
rotocol included routine 6- to 9-month angiographic
ollow-up. Unscheduled angiography was allowed on the
asis of clinical indication.
The study was approved by the institutional review
ommittee, and all patients gave informed written consent
o undergo intervention and participate in the study.
tatistical analysis. Discrete data are summarized as fre-
uencies, whereas continuous data are mean  SD or
edian (interquartile range), as appropriate. The chi-square
est was used for comparison of categorical variables, and the
npaired 2-tailed Student t test or Mann-Whitney rank-
um test was used to test differences among continuous
ariables. Survival curves were generated using the Kaplan-
eier method, and the difference between groups was
ssessed by a log-rank test. The multivariable analysis to
valuate the independent contribution of clinical, angio-
raphic, and procedure variables to the primary endpoints
as performed by a forward stepwise Cox proportional
azards model. The variables entered into the model were
ge (years), male sex, diabetes mellitus, serum creatinine
evel 150 mol/l, history of myocardial infarction, acute
oronary syndrome on admission, left ventricular ejection
raction 40%, left main plus 3-vessel coronary disease,
ight coronary artery CTO, left anterior descending artery
TO, left circumflex artery CTO, EuroSCORE 6, left
ain bifurcation lesion, left main stenting of both branches,
eft main stent length 24 mm, abciximab use, intra-aortic
alloon counterpulsation, and Thrombolysis In Myocardial
nfarction major bleeding (11). A Cox proportional hazards
odel was used to test interaction among covariates. A
ropensity score analysis was performed using a logistic regres-
ion model from which the probability for a patent right
oronary artery was calculated for each patient. Model discrim-
nation was assessed with the c-statistic and goodness-of-fit
ith Hosmer and Lemeshow test. Thereafter, a Cox multi-
ariate analysis was performed to adjust right coronary CTO
or a propensity score. A p value 0.05 was considered
ignificant. Analyses were performed using the software pack-
ge SPSS version 11.5 (SPSS Inc., Chicago, Illinois).
esults
rom January 2004 to December 2009, 374 patients under-
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July 5, 2011:125–30 RCA Occlusion in Left Main PCIanalysis. Table 1 shows the baseline characteristics of the
330 patients eligible for the study.
Of the 330 patients, 78 (24%) had a right coronary artery
CTO. CTO of the left anterior descending artery or left
circumflex artery was revealed in 21 patients (6%) and 19
patients (6%), respectively.
The majority of patients were high surgical risk patients
(182 patients had a EuroSCORE of 6). Patients with
right coronary artery CTO had a higher risk profile com-
pared with patients without right coronary artery CTO with
a higher EuroSCORE (median score 9.6 and 6.1, respec-
tively; p  0.002) and a lower left ventricular ejection
raction (39 14% and 47 12%, respectively; p 0.001).
oreover, more patients in the right coronary artery CTO
roup had severe disease of both the left anterior descending
rtery and circumflex artery (49% and 33%, respectively; p
.001), and 8 patients had a double CTO.
Table 2 shows the procedure characteristics. Placement of
single stent in the left main and left anterior descending
rteries was accomplished more frequently in the right
oronary CTO group, whereas there were no differences
etween groups with regard to the other procedure charac-
eristics (stenting technique, use of rotational atherectomy,
otal stent length, type of DES, use of abciximab, use of
ntra-aortic balloon counterpulsation). Right coronary artery
TO PCI attempt was performed in 39 patients (50%).
easons to not attempt the CTO PCI were: 1) no evidence
f a significant area of viable myocardium in the territory




Age, yrs 72 10
Male 259 (78)
Current smokers 62 (19)
Arterial hypertension 256 (77)
Diabetes mellitus 98 (30)
Hypercholesterolemia 215 (65)
Peripheral vascular disease 105 (32)
Previous myocardial infarction 83 (25)
Previous PCI 114 (35)
NSTEMI 58 (18)
Unstable angina 177 (54)
Creatinine 150 mol/l 59 (18)
LVEF, % 45 13
LVEF 40% 177 (54)
EuroSCORE 6.8 (3.4–18.6)
EuroSCORE 6 182 (55)
LM plus 2-vessel disease 142 (43)
LM plus 3-vessel disease 96 (28)
CTO lesion 118
Left anterior descending artery 21 (6)
Circumflex artery 19 (6)
Distal LM location 283 (86)
Value are mean  SD, n (%), median (interquartile range), or n.
CTO  chronic total occlusion; LM  left main; LVEF  left ventricular ejection
 percutaneous coronary intervention; RCA  right coronary artery.upplied by the right coronary artery (n  20); 2) renal
nsufficiency contraindicating the use of a large amount of
ye (n  7); and 3) a low likelihood of PCI success as
valuated by the operator (n 12). Of the 39 right coronary
rtery CTO PCIs attempted, 21 (54%) were performed in
he same left main procedure, whereas 18 were staged. In all
ases, the left coronary artery procedure was performed first,
nd the decision to stage or not to stage the right coronary
rtery CTO PCI was made according to the procedure time,
uoroscopy time, and amount of contrast used for the left
oronary artery procedure. Right coronary artery CTO PCI
as successful in 35 patients (90%). Most of the occlusions
ere treated with long stents and multiple stents (median
tent length, 43 mm; interquartile range, 35 to 56 mm). PCI
as attempted in 19 of 21 patients with left anterior
escending artery CTO and was successful in 18 patients,
hereas PCI was attempted in 13 of 19 patients with left
ircumflex artery CTO and was successful in 11.
Overall, complete revascularization was achieved in 77% of
atients. Complete revascularization was achieved in 44% of
atients with right coronary artery CTO and 88% of patients
ithout right coronary artery CTO (p  0.001). As a conse-
uence, the majority of patients without complete revascular-
zation (59%) had CTO of the right coronary artery.
Table 3 and Figure 1 summarize the clinical outcome. The
edian length of follow-up was 16.1 months (interquartile
ange: 6.4 to 37.8 months), and the follow-up rate was 100%.
t 6 months, the cardiac mortality rate was 12.8% in patients
Without RCA CTO
n  252)
Patients With RCA CTO
(n  78) p Value
72 10 71 11 0.728
2 (76) 67 (86) 0.782
7 (19) 15 (19) 0.909
6 (78) 60 (77) 0.874
1 (28) 27 (35) 0.277
5 (65) 50 (64) 0.824
7 (31) 28 (36) 0.376
9 (23) 24 (31) 0.191
2 (36) 22 (28) 0.178
0 (16) 18 (23) 0.144
5 (54) 42 (54) 0.917
1 (16) 18 (23) 0.170
47 12 39 14 0.001
5 (54) 42 (54) 0.966
1 (3.2–14.5) 9.6 (4.5–28) 0.002
9 (51) 53 (68) 0.009
5 (42) 37 (47) 0.368
8 (33) 38 (49) 0.001
33 85
9 (7.5) 2 (2.6) 0.116
4 (5.6) 5 (6.4) 0.777




















21fraction; NSTEMI  non–ST-segment elevation myocardial infarction; PCI
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RCA Occlusion in Left Main PCI July 5, 2011:125–30with right coronary artery CTO and 3.6% in patients without
right coronary artery CTO (p 0.002). The 6-month cardiac
mortality rate was 8.6% in patients with successfully treated
right coronary artery CTO and 16.3% in patients with un-
treated coronary artery CTO or failed right coronary artery
CTO PCI (p 0.311). The 6-month mortality rate was 4.8%
and 0% in patients with CTO of the left anterior descending
artery and left circumflex artery, respectively. The 3-year
cardiac survival rates was 76.4  6.8% in patients with right
oronary artery CTO and 89.7  2.7% in patients without
right coronary artery CTO (p  0.003).
Most of cardiac deaths (83%) occurred in patients with a
EuroSCORE of 6.
No significant interactions were found between right
coronary artery CTO and other covariates.
By multivariable analysis, the only 2 independent predictors
of 3-year cardiac mortality were right coronary artery CTO
(hazard ratio: 2.15, 95% confidence interval: 1.02 to 4.50; p
0.043) and EuroSCORE (hazard ratio: 1.03, 95% CI: 1.02 to
1.05; p  0.001). Multivariable analysis was also performed
using the propensity score and right coronary artery CTO as
covariates. The c-statistic of the regression model of the
propensity score was 0.83 (Hosmer and Lemeshow goodness-
of-fit test, p 0.323). After adjusting for the propensity score,
right coronary artery CTO remained significantly related to
the risk of cardiac death (hazard ratio: 2.37, 95% confidence
interval: 1.09 to 5.15; p  0.029).






(n  78) p Value
LM stenting alone 49 (19) 7 (9) 0.092
Single LM-LAD stenting 100 (40) 42 (54) 0.027
Single LM-LCx stenting 17 (7) 5 (6) 0.508
LM stenting of both branches 86 (34) 24 (31) 0.582
T-stenting 55 19
Crush stenting 24 5
V-stenting/culotte stenting 7 0
Rotablator 19 (8) 6 (8) 0.731
Total LM stent length, mm 22 11 21 13 0.692
IVUS guidance 82 (32) 23 (29) 0.613
Abciximab 138 (55) 37 (47) 0.257
IABP 17 (7) 10 (13) 0.087
Stent type 0.909
Sirolimus-eluting 30 (12) 11 (14)
Paclitaxel-eluting 169 (67) 52 (67)
Everolimus-eluting 53 (21) 15 (19)
Maximum pressure inflation, atm 20 3 20 3 0.939
RVD pre-PCI, mm 3.64 0.39 3.67 0.39 0.553
MLD post-PCI, mm 3.71 0.34 3.73 0.33 0.648
CTO PCI attempted 26/33 (79) 43/85 (51) 0.005
CTO PCI success 23/26 (88) 40/43 (93) 0.515
Values are n (%), n, or mean  SD.
IABP intra-aortic balloon pump; IVUS coronary intravascular ultrasound; LAD left anteriordescending artery; LCx  left circumflex artery; MLD  minimum lumen diameter; RVD 
reference vessel diameter; other abbreviations as in Table 1.The angiographic follow-up rate was 88% (n 290). The
left main angiographic restenosis rate was 12%.
Discussion
The main findings of the present study are the following:
1) more than one-third of patients undergoing PCI for
Figure 1 Long-Term Survival
Kaplan-Meier analysis of cardiac survival for patients with and without
right coronary artery chronic total occlusion (RCA CTO).






(n  78) p Value
6-month outcome
Overall mortality 13 (5.2) 11 (14) 0.008
Cardiac mortality, 9 (3.6) 10 (12.8) 0.002
RCA CTO PCI success, % 8.6*
RCA CTO none or failed, % 16.3*
MI 2 (0.8) 1 (1.3) 0.691
Left main rePCI 30 (11.9) 6 (7.7) 0.297
Any revascularization, % 51 (20) 16 (20) 0.958
PCI 51 16
CABG 0 0
Stroke 0 1 (1.3) 0.072
Long-term outcome†
Cardiac mortality 0.003
1-yr, % (n  210) 4.7 1.4 12.9 3.8
2-yr, % (n  138) 6.1 1.7 19.2 5.6
3-yr, % ( n  95) 10.3 2.6 23.6 6.8
3-yr MI, % 6.3 4.3 13.1 7.3 0.065
Any 3-yr revascularization, % 43.5 4.7 45.7 8.7 0.155
Values are n (%), n, or mean  SD. *p  0.311. †Kaplan-Meier estimate.
CABG  coronary artery bypass grafting; CTO  chronic total occlusion; MI  myocardial
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July 5, 2011:125–30 RCA Occlusion in Left Main PCIULMD have at least 1 CTO, and right coronary artery
CTO was revealed in nearly one-fourth of patients; 2) right
coronary artery CTO is a predictor of mortality; 3) right
coronary artery CTO PCI is attempted less frequently than
left anterior descending artery or circumflex artery CTO
PCI; 4) the completeness of revascularization in patients
with disease of vessels other than the left main coronary
artery is frequently dependent on successful revasculariza-
tion of right coronary artery CTO; 5) other angiographic
features such as distal left main disease or 3-vessel disease
have no significant impact on survival; and 6) the Euro-
SCORE is a valid score for the definition of the risk of
patients undergoing PCI for ULMD.
Coronary CTO occurs frequently, and registry studies
report an incidence of 30% to 50% in patients with
significant coronary artery disease undergoing coronary
angiography (12–15). CTO is the most frequent reasons for
referral of patients who need revascularization for coronary
artery bypass graft surgery (12–15), and this fact may explain
the relatively low incidence of right coronary artery CTO in
previous studies on ULMD PCI, including the randomized
SYNTAX trial (7). In the SYNTAX trial, only 10% of
patients randomized to PCI had right coronary artery CTO,
whereas the incidence of CTO was 56.4% in patients
excluded from randomization and enrolled in the coronary
bypass graft registry (7).
In this study, right coronary artery CTO was revealed in
nearly one-fourth of patients who underwent ULMD PCI.
This finding may be explained by the fact that, in 2004, with
the unrestricted availability of DES, specific institutional
programs for routine percutaneous treatment of CTO and
ULMD started (16,17).
Right coronary artery CTO is independently related to
the risk of cardiac death. It has been shown that in patients
with multivessel disease undergoing PCI, incomplete revas-
cularization due to untreated CTO carries a higher risk of
mortality compared with patients with complete revascular-
ization (9,18). Patients with successful PCI of right coro-
nary artery CTO had a lower mortality rat compared with
patients with no or a failed PCI; however, this difference did
not reach significance. Moreover, in this cohort of patients,
one-half of patients with right coronary artery CTO had no
indication for PCI because of the lack of viable myocardium
or renal insufficiency that may be associated with an in-
creased risk of death. Thus, right coronary artery CTO
might be linked to mortality also through associated comor-
bidities known to have a significant impact on mortality.
Conversely, CTO of the left anterior descending artery or
circumflex artery PCI was attempted in the majority of
patients, indicating the presence of viable myocardium and
the lack of renal insufficiency contraindicating the use of
large amount of dye or a relatively less severe atherosclerotic
burden making a PCI attempt likely successful.
In this study, coronary anatomy features other than right
coronary artery CTO such as 3-vessel disease and a distal
location of left main disease and CTO of the left anteriordescending artery or left circumflex artery had no impact on
survival. Again, this finding may be related to more fre-
quently achieving complete revascularization in these sub-
sets of patients or to a better risk profile allowing PCI to be
attempted more frequently and with a high likelihood of
success. This finding is not consistent with the results of the
SYNTAX trial. In the 357 patients randomized to PCI of
the ULMD-SYNTAX substudy, the mortality rate in-
creased with the increase in the diffusion and angiographic
complexity of coronary artery disease. The 1-year mortality
rate in patients with more complex coronary disease as
defined by a SYNTAX score of 33 was 9.7% compared
with the 0.9% and 1% of patients with low (SYNTAX score
of 22) or intermediate morphological complexity
(SYNTAX score of 23 to 32), respectively (8). The major
differences between the 2 patient populations may help to
explain these discrepancies: the randomized SYNTAX pop-
ulation had a lower EuroSCORE (3.9  2.8) and a lower
ncidence of right coronary artery CTO (10.1%) and of
omplete revascularization (complete revascularization was
chieved in 64.5% of patients randomized to PCI) com-
ared with this patient cohort (8).
In this study, the EuroSCORE was a good predictor of
ortality, and this finding is consistent with most of the
revious studies on ULMD PCI showing that this scoring
ystem based on clinical variables is a valid predictor of
atient outcome (4,6,8,19).
tudy limitations. One limitation of the study involves the
ack of a surgical group. This would have allowed the
ssessment of the value of revascularization of occluded
essels for which a PCI attempt was deemed not indicated.
owever, this comparison was beyond the aim of this study.
nother limitation is the relatively small number of patients
nd events that make possible type II errors in which
ifferences in baseline or procedure characteristics are not
ound to be predictors of long-term outcome, but that in a
arger study could be statistically significant. The high
umber of predictors screened by stepwise analysis may
esult in an overfitting. However, to resolve this problem
nd to yield consistent results, we performed a propensity
core–adjusted analysis. It must be acknowledged that this
tudy does not show a cause-and-effect relationship between
he presence of right coronary artery CTO and mortality but
nly an association. Therefore, the results of the study are
nly hypothesis generating.
onclusions
he results of this study show that right coronary artery
TO occurs frequently and is a significant predictor of
ortality in patients with ULMD undergoing PCI.
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